Por: ABC7 Health December 08, 2022
PHILADELPHIA -- Children as young as 6 months are now eligible to receive an updated Covid-19 vaccine.The US Food and Drug Administration on Thursday authorized updated Covid-19 vaccines from Moderna and Pfizer/BioNTech for use in children from ages 6 months through 5 years.The bivalent vaccines target the original strain as well as the BA.4/5 Omicron strains. Bivalent vaccines were previously authorized as a booster for people age 5 and... + full article
RTTNews USA Health December 06, 2022
Vaccine partners Pfizer Inc. and BioNTech SE are seeking emergency use authorization or EUA from the U.S. Food and Drug Administration to offer their bivalent COVID-19 vaccine to children 6 months through 4 years of age. If authorized, the vaccine would be part of a primary... + más
FDA greenlights bivalent vaccines for children as young as 6 months old | Politico
Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica
Los Angeles Times USA Nation November 24, 2022
A California appeals court ruled against the San Diego Unified School District's COVID-19 student vaccine mandate, which has been on pause for the last half-year. The 4th District Court of Appeal agreed Tuesday with a lower court's ruling from December that school... + más
For subscribers: San Diego Unified race becomes partisan brawl | Los Angeles Times
Judge orders NYPD union members fired over vax mandate reinstated | New York Post
ABC News USA Health November 04, 2022
Pfizer and BioNTech have launched a clinical trial on a vaccine targeting both COVID-19 and influenza, the companies Thursday.The phase 1 trial is being done in the United States with 180 participants between the ages of 18 and 64, with the first participant dosed this week, the... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
CNN USA Health October 19, 2022
CNN — The US Food and Drug Administration on Wednesday among adults 18 and older, at least six months after completing a primary Covid-19 vaccine series. The company announced that it has received emergency use authorization to provide a first booster dose of its vaccine... + más
FDA authorizes Novavax's Covid shots as mix-and-match booster to Pfizer or Moderna | CNBC
US clears Novavax COVID booster dose | ABC News
ABC7 USA Health October 18, 2022
in an interview over the weekend. Her husband, professor Ugur Sahin, with whom she cofounded the German pharmaceutical company BioNTech, said he thought cancer vaccines could be widely available before 2030.The husband-and-wife duo founded BioNTech in 2008 originally to develop... + más
Cancer vaccine may be ready by 2030, say founders of COVID vaccine makers BioNTech | ABC News
In Boston visit, BioNTech’s leaders say the pandemic isn’t close to being over | The Boston Globe
ABC News USA World October 18, 2022
LONDON -- The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine.We feel that a cure for cancer or to changing cancer patients' lives is in our grasp, professor Ozlem Tureci told in an interview... + más
Cancer vaccine may be ready by 2030, say founders of COVID vaccine-makers BioNTech | ABC7
RTTNews USA Health September 24, 2022
Getting an updated Covid vaccine this fall will help restore protection that has waned since previous vaccination, according to the White House Covid-19 Response Team.Laboratory data suggests that the addition of the Omicron BA.4 and BA.5 spike protein components may help... + más
Pfizer, BioNTech ask FDA to approve updated COVID booster for ages 5-11 | WPTV
US officially added to WHO’s list of poliovirus outbreak countries | Ars Technica
About iurex | Privacy Policy | Disclaimer |